A carregar...
Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
BACKGROUND: Antiangiogenic agents that specifically target vascular endothelial growth factor receptor (VEGFR), such as sunitinib, have been utilized as the standard therapy for metastatic clear cell renal cell carcinoma (ccRCC) patients. However, most patients eventually show no responses to the ta...
Na minha lista:
| Publicado no: | Front Genet |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8299280/ https://ncbi.nlm.nih.gov/pubmed/34306023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2021.680369 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|